Investing Profile

Paul Berns

InvestorVC
Managing Director at ARCH Venture Partners
Photo of Paul Berns, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$25.0M
11
$635.8M
CompanyStageDateRound SizeTotal Raised
Matter Neuroscience
SeedFeb 2024$26M
$26M
Co-investors: Amir Nashat (Polaris Partners)
Areteia Therapeutics
Series AFeb 2024$75M
Series AJul 2022$350M
$430M
Co-investors: Adam Koppel (Bain Capital Life Sciences)
Human Immunology Biosciences
Series BJan 2024$95M
Series ANov 2022$120M
$220M
Co-investors: Carol Suh (ARCH Venture Partners)
Elephas
Series CNov 2023$55M
Series BSep 2022$42M
$97M
Happy Health
Series AAug 2022$60M
$60M
Epirium Bio
Series ADec 2019$85M
$86M
Co-investors: Christopher de Souza (Broadview Ventures)
BlackThorn Therapeutics
Series BJun 2019$76M
Series AOct 2016$40M
$130M
Co-investors: Brian Chee (Polaris Partners), Lori Hu (Vertex Ventures), Julie Sunderland (Biomatics Capital Partners)